Category: CovidienSyndicate content

Medtronic founder Bakken backs Covidien buy

August 15, 2014 by Brad Perriello

Earl Bakken, the founder of Medtronic, tells employees he's behind the company's $43 billion acquisition of Covidien and its potential to save a life every second.

Medtronic founder Bakken backs Covidien buy

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FTC wants more data on MDT-COV deal | Medtech Wall Street news for the week of August 11, 2014

August 14, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; Greatbatch acquires Uruguay's CCC Medical Devices; T2 Biosystems IPO raises $57M for MRI-based diagnostics; Strong Q4, $750M buyback give CareFusion a boost; Baxano: Strong Q2, new patents can't appease Wall Street

FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried

August 7, 2014 by Arezu Sarvestani

Analyst report: Dems can't stop Medtronic-Covidien merger

Allergan calls out Valeant on latest earnings report : The week in medtech M&A

August 13, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Valeant's hostile takeover hopes fade as Allergan war continues; Medtronic hires ex-Senators to lobby for Covidien deal; FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; St. Jude closes $200M NeuroTherm buy; Medtronic-Covidien merger means tax hit for all stockholders, including execs

Report: Valeant's hostile takeover hopes fade as Allergan war continues

August 6, 2014 by Arezu Sarvestani

Allergan attacks activist investor's latest earnings report

Another Covidien shareholder sues to block Medtronic merger

August 12, 2014 by Brad Perriello

Another Covidien shareholder sues to block the pending, $43 billion merger with Medtronic, arguing that the deal violates both American and Irish laws.

Another Covidien shareholder sues to block Medtronic merger

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic-Covidien merger means tax hit for all stockholders, including execs

August 11, 2014 by Arezu Sarvestani

The terms of Medtronic's unusual $43 billion acquisition of Covidien means that all MDT shareholders are subject to paying a capital gains tax, including executives and board members.

Medtronic-Covidien merger means tax hit for all stockholders, including execs

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic hires ex-Senators to lobby for Covidien deal

August 11, 2014 by Arezu Sarvestani

Medtronic engages former Senators Trent Lott and John Breaux to lobby on behalf of the company's $43 billion acquisition of Covidien and its subsequent move overseas.

Medtronic hires former Senators to lobby on Covidien deal

Medtech titan Medtronic (NYSE:MDT) has a few heavy-hitters in its corner during its fight against anti-corporate inversion measures on Capitol Hill.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried

August 7, 2014 by Arezu Sarvestani

Despite the furor on Capitol Hill, lawmakers aren't likely to produce reform that will hinder Medtronic's $43 billion acquisition of Covidien, according to Morgan Stanley analysts.

Analyst report: Dems can't stop Medtronic-Covidien merger

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp